MedTrace Logo

The Effects of Dexmedetomidine on Peroperative Shivering Incidence Under Spinal Anesthesia

NCT01921361 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-08-13

No results posted yet for this study

Summary

The purpose of this study to compare the efficacy of intravenous or intrathecal dexmedetomidine on the incidence of shivering on patients who scheduled spinal anesthesia for elective surgery.

Conditions

  • Perioperative/Postoperative Complications

Interventions

DRUG

Levobupivacaine

Intrathecal 3ml (15 mg)

DRUG

Dexmedetomidine

Intrathecal 3 microgram (diluted 1/10, 0.3 ml)

DRUG

Dexmedetomidine

Intravenous 1ml/kg/10 minutes and than 0.5 ml/kg/hour infusion (dexmedetomidine diluted 1 microgram/ml)

DRUG

sodium chloride

Intravenous 1ml/kg/10 minutes and than 0.5 ml/kg/hour infusion in the control and intrathecal groups, intrathecal 0.3 ml in the control and intravenous groups.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Resul Altuntas, MD · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01921361 on ClinicalTrials.gov